Carbimide

Carbimide

SCHEMBL4969122

N=C=N.O=C1CC(O)C(=O)N1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 1/20 0.43
CRBN Q96SW2 1/20 0.36
CYP19A1 P11511 1/20 0.33
MEN1 O00255 1/20 0.33
APEX1 P27695 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.31
IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbimide SCHEMBL28503694 0.98 MAP3K14 (0.41) MAP3K14CRBNCYP19A1MEN1APEX1
SCHEMBL15494454 0.91
SCHEMBL11288 0.91
Ammonia Solution, Strong SCHEMBL25176856 0.88
Hydrochloric Acid SCHEMBL3986242 0.88
Phosphine SCHEMBL22345181 0.88
SCHEMBL31244467 0.88
SCHEMBL320576 0.88
SCHEMBL26961132 0.86 MAP3K14 (0.43) MAP3K14CRBNCYP19A1MEN1APEX1
Hydrochloric Acid SCHEMBL28901164 0.86 MAP3K14 (0.46) MAP3K14CRBNCYP19A1MEN1APEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115337222-B Hollow collagen structure, and preparation method and application thereof 爱美客技术发展股份有限公司 2023-08-25 CN claimed
CN-115337222-A Hollow collagen structure body and preparation method and application thereof 爱美客技术发展股份有限公司 2022-11-15 CN claimed
CN-115337222-B Hollow collagen structure, and preparation method and application thereof 爱美客技术发展股份有限公司 2023-08-25 CN disclosed
CN-115337222-A Hollow collagen structure body and preparation method and application thereof 爱美客技术发展股份有限公司 2022-11-15 CN disclosed
EP-1397153-B1 METHODS FOR PROTECTING ALLOGENEIC ISLET TRANSPLANT USING SOLUBLE CTLA4 MUTANT MOLECULES BRISTOL MYERS SQUIBB CO (US) 2008-04-02 EP disclosed